• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AI
Click for more information
0.00% 0.9¢

ALGORAE PHARMACEUTICALS LIMITED - Charts / Financials

Market Cap $15.18M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.25pm 22/07/2024 (20 minute delay) ?
Day
Open 0.9¢   Day High 1.0¢   Day Low 0.9¢
Daily Volume 780359
Bids   Sellers
Number Price Volume   Number Price Volume
1 0.9¢ 35383   1 1.0¢ 280097

Directors & Senior Management

Mr. David Richard Hainsworth Executive Chairman of the Board
Mr. Daya Uka Chief Financial Officer
Dr. Belinda Di Bartolo Chief Operating Officer
Dr. James A. Mckenna Chief Scientific Officer
Dr. Carolyn M. Sue Chief Medical Officer
Ms. Jennifer Voon Company Secretary
Mr. Bradley John Dilkes Director
Mr. Bradley Roland Latham Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
0.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $15.18M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $7.027K 780.3K

Buyers (Bids)

No. Vol. Price($)
1 35383 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 280097 1
View Market Depth
Last trade - 15.57pm 22/07/2024 (20 minute delay) ?
Last
0.9¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
0.9¢ 0.9¢ 0.9¢ 70215
Last updated 15.25pm 22/07/2024 ?

Top Stories

HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group

Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo.
Large fault structure and uranium anomalies picked up by Infini at Newfoundland play Infini Resources Ltd has revealed the presence of a large fault structure connected to anomalies at its Portland Creek uranium project.
High-grade copper results provide some relief to 29Metals after earlier mine shutdown 29Metals Ltd has reported positive results from a 3-hole program of drilling in Queensland, finding up to 4.8% copper.
Pure Hydrogen inks MOU for 5 hydrogen buses in Saigon – days after Twiggy's FFI reeled back in Pure Hydrogen has confirmed it's executed an MOU with a Vietnam-based entity to develop hydrogen-fuelled buses.
Biden's exit bakes in a Kamala Harris ballot while markets expect Trump to win. How could equities fare this week? Joe Biden, current US President, has agreed to drop out of the 2024 Presidential election following internal disagreement.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.